NBO Pharma Inc. — Form D
NBO Pharma Inc. of BEDFORD, NY, a company, filed a Form D exempt-offering notice with the SEC on 2026-01-22. The offering totals $7.6M, of which $7.6M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2026-01-22
- Form: D
- Accession: 0002103906-26-000001
- Industry: Pharmaceuticals
- Exemptions: 06c
- Total offering: $7.6M
- Amount sold: $7.6M
- Minimum investment: $10K
- Investors: 93
- Date of first sale: 2025-06-12
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-570878
Issuer
- Name: NBO Pharma Inc.
- CIK: 0002103906
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2021
- Address: 64 QUARRY LANE, BEDFORD, NY, 10506
- Phone: 914-645-1130
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| Colin David Foster | Director | Woodbridge, CT |
| Robert David Friedman | Director | Teaneck, NJ |
| Bard David Geesaman | Director | Marlboro, MA |
| Fredric David Price | Director | Bedford, NY |
| Fredric David Price | Executive Officer | Bedford, NY |
More